Nursing care
Methadone Maintenance: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Methadone maintenance treats opioid use disorder by preventing withdrawal and blunting cravings through a long-acting opioid agonist. The danger is its long half-life: the drug accumulates faster than its effects appear, so the highest overdose risk sits in the first two weeks of titration, not at a stable dose. Baseline and periodic ECGs monitor for QT prolongation.
What it does and why it is prescribed
Methadone is a full opioid agonist used in supervised maintenance programmes to treat opioid use disorder. It occupies the same receptors as heroin or prescription opioids but with a slow onset and a long duration, so a once-daily dose prevents withdrawal without producing the peaks and troughs that drive drug-seeking behaviour.
The goal is stabilisation, not detoxification in the short term. Patients attend a licensed opioid treatment programme, often daily at first, for observed dosing. This structure exists because the drug's pharmacokinetics make unsupervised titration dangerous, which is the point of the next section.
Nursing considerations before giving it
Confirm identity against the programme's photo record and dosing card before every administration; diversion and misidentification are real risks in a clinic setting. Check the most recent dose and any missed days. A gap of three or more missed doses can mean lost tolerance, and the prescriber may need to restart titration at a lower dose rather than resume the prior one.
Review the ECG history. Methadone prolongs the QT interval in a dose-dependent way, so a baseline ECG is standard before induction, with a follow-up around 30 days and periodically thereafter, or sooner if the dose rises quickly or other QT-prolonging drugs are added. Ask about other CNS depressants the patient may be taking, including benzodiazepines and alcohol, since combined use is a leading cause of methadone-related deaths.
What to monitor
Respiratory rate and sedation level are the primary safety checks, especially during the first two weeks of induction when methadone is accumulating in tissue faster than its clinical effect builds. A patient can look adequately dosed on day three and be dangerously sedated by day seven as steady state is reached, so early titration weeks warrant closer follow-up than the dose alone suggests.
Track the QTc on scheduled ECGs and flag anything approaching 500 milliseconds. Monitor for signs of withdrawal, which suggest under-dosing, against signs of sedation, which suggest accumulation. Pupil size, speech pattern, and level of alertness at each visit give a quick read on where the patient sits between those two states.
Side effects versus adverse effects
Expected side effects mirror any opioid: constipation, sweating, mild sedation, and reduced libido. These are managed supportively; constipation in particular needs a standing bowel regimen since it does not resolve with tolerance the way sedation does.
Adverse effects are different in kind, not degree. Respiratory depression, QT prolongation with torsades risk, and severe hypotension are dose-related dangers rather than nuisance effects. A patient who is drowsy but rousable and breathing at 14 a minute is having an expected effect; a patient who is difficult to rouse or breathing at 8 a minute is having an adverse one, and that distinction should drive the response, not the dose number on the chart.
What to hold for and when to call
Hold the dose and notify the prescriber for a respiratory rate under 12, oxygen saturation that will not correct with a brief arousal, pinpoint pupils with sedation, or a QTc that has crossed the facility's threshold since the last reading. Also hold for reported use of another CNS depressant since the last dose, since the additive respiratory risk changes the calculation even if the patient looks stable.
Call immediately, rather than simply holding, for any sign of overdose: unresponsiveness, shallow or absent breathing, or cyanosis. Naloxone should be available wherever methadone is administered, though staff should know it has a shorter half-life than methadone and repeat dosing or close observation is often needed after reversal.
Patient teaching
Teach patients that methadone builds up in the body over the first one to two weeks, so a dose that feels fine on day one can become too strong by day ten even without any change in prescription. This is the single most important safety message for anyone new to the programme, and it is worth repeating rather than assuming it was absorbed at intake.
Cover the interactions that matter most: no alcohol, no unsanctioned benzodiazepines, and a call to the clinic before starting any new prescription, since several common antibiotics and antidepressants also prolong the QT interval. Advise patients to report palpitations, fainting, or unusual sedation rather than waiting for the next scheduled visit, and to keep every ECG and dosing appointment even when they feel well, since stability is exactly when the risk of complacency is highest.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our mental health practice questions are the closest set to what this page covers.
Common questions
Why is the overdose risk highest in the first two weeks of methadone treatment?
Methadone's plasma half-life is much longer than its clinical duration of action, so the drug keeps accumulating in tissue for several days after each dose increase before reaching steady state. A patient can appear adequately controlled while blood levels are still climbing toward a sedating or respiratory-depressant concentration, which is why induction and early titration carry the highest risk.
How often is an ECG needed during methadone maintenance?
A baseline ECG is standard before starting or shortly after induction, with a follow-up around 30 days, and periodic monitoring after that, more often if the dose is increased quickly or other QT-prolonging medications are introduced. Practice varies by programme, so follow the treatment centre's protocol.
What is the difference between opioid withdrawal and methadone overdose signs?
Withdrawal presents with agitation, dilated pupils, muscle aches, and gastrointestinal upset, while overdose presents with sedation, pinpoint pupils, and slowed or absent breathing. The two require opposite responses, so pupil size and respiratory rate together are more reliable than either sign alone.
Can a patient take their methadone dose home?
Take-home privileges depend on programme rules and are typically earned over months of demonstrated stability, verified attendance, and negative screens for other substances. Supervised daily dosing is the default at the start of treatment because of the accumulation risk during titration.
More on mental health